Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer - Contacts and Locations

Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00004205

Locations


Denmark
	Rigshospitalet
	Copenhagen, Denmark, 2100

France
	Institut Bergonie
	Bordeaux, France, 33076

Switzerland
	Kantonsspital - St. Gallen
	St. Gallen, Switzerland, CH-9007

Sponsors and Collaborators

International Breast Cancer Study Group

Federation Nationale des Centres de Lutte Contre le Cancer

Danish Breast Cancer Cooperative Group

Investigators


Study Chair:	Beat Thurlimann, MD	Kantonsspital - St. Gallen

Study Chair:	Louis Mauriac, MD	Institut Bergonie

Study Chair:	Henning T. Mouridsen, MD, PhD	Rigshospitalet, Denmark